Should You Buy Injective in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been monitoring the evolution of the Injective cryptocurrency for over three years. Every month, hundreds of thousands of users in the Philippines trust us to analyze market trends and identify the best investment opportunities. Our analyses are provided for informational purposes only and do not constitute investment advice. In accordance with our ethical guidelines, HelloSafe has never purchased Injective nor received any compensation from entities associated with its ecosystem.

Injective in brief

How much does 1 Injective cost?

The price of Injective is up this week. As of today, INJ is trading at around ₱757.00, with a 24-hour increase of +6.42% and solid weekly growth. Its current market capitalization stands at approximately ₱75.7 billion, with an average 3-month daily trading volume near ₱5.5 billion, placing Injective at rank #48 among global cryptocurrencies. There are about 97.7 million INJ tokens in circulation, representing almost 0.10% of the total crypto market cap. As with most digital assets, expect significant volatility—offering both risk and opportunity for investors in the Philippines.

Our full opinion on the Injective crypto

Have we truly understood the new momentum emerging around Injective after a significant year of recalibration and development? Our team has systematically analyzed the latest trends in Injective (INJ), dissecting its evolution over the past three years by leveraging proprietary algorithms that synthesize on-chain indicators, technical signals, market data, and the competitive ecosystem. So, why might Injective once again represent a strategic entry point into the next era of DeFi and interoperable Layer-1 ecosystems in 2025?

Recent Performance and Market Environment

Price Evolution

Since mid-2022, Injective’s price action has demonstrated both resiliency and volatility. After peaking above $28 in 2023, INJ retraced significantly, currently trading around $12.90 as of June 2025—markedly off its all-time highs, yet displaying clear signs of stabilization. Notably, the asset has recorded a +6.4% gain over the past 24 hours and shows short-term upside momentum. Year-to-date performance reflects the broader market consolidation, with INJ down ~57% from prior highs, yet this reset has arguably improved its risk/reward profile and set the stage for a potential upward cycle.

Positive Catalytic Events

• Google Cloud, BitGo, and Deutsche Telekom have onboarded as validators in 2025, underscoring rising institutional confidence.
• Technological upgrades, such as the launch of Injective 3.0 and the pioneering iAgent SDK for DeFi x AI use cases, have expanded the protocol’s value proposition.
• With more than 2 billion transactions processed seamlessly, operational reliability is confirmed and is now a key competitive differentiator.

Macro and Sectoral Context

Layer-1 platforms optimized for DeFi are again in the spotlight as traditional finance progressively explores blockchain integrations. Regulatory clarity is improving in key jurisdictions, and capital flows into the crypto sector have recovered post-2024. Within this context, Injective’s focus on interoperability and real-world asset (RWA) DeFi positions it as a cornerstone protocol for both retail and institutional adoption in the coming cycle.

Technical Analysis

Crypto Indicators

• RSI (14d): Near 48, signals a reset to neutral, indicating neither overbought nor oversold conditions—a constructive base for new positioning.
• MACD and Moving Averages: While some short-term averages display a slightly bearish tilt following the recent correction, emerging divergences suggest a readiness for mean-reversal upside should market momentum firm up.
• Support levels: Robust at $11.26–$11.28, with clear market reactions, bolstered by high-volume buying on dips.
• Resistance: $14.16–$15.66 remains the near-term technical test; a decisive break could trigger accelerated buying momentum and short-covering.

Momentum & Structural Setup

INJ’s sideways movement amid rising volumes hints at healthy consolidation, often a precursor to further expansion. On-chain flows and exchange order books now reflect accumulating interests, particularly from mid-sized wallets, suggesting bullish preparation ahead of upcoming events (notably, the June Injective Summit).

Fundamental Analysis

Adoption, Partnerships & Ecosystem Growth

• Strategic Partnerships: Google Cloud’s commitment as a validator, together with BitGo’s and Deutsche Telekom’s recent onboardings, provides strong institutional endorsement, boosting trust among major players.
• Growing Ecosystem: The arrival of iAgent SDK is unlocking new AI-powered DeFi use cases and stimulating developer activity. A robust DEX infrastructure and zero-gas-fee trading reinforce user stickiness and capital attraction.
• Market Metrics: With $1.29 billion market cap and attractive circulating supply dynamics (97.7M INJ out of a max 100M minted), INJ enjoys ongoing scarcity benefits—an uncommon tokenomic feature versus inflationary rivals.

Structural Strengths

• Tech Differentiation: As a Layer-1 protocol designed ground-up for finance, Injective’s interoperable architecture (Cosmos-based) and zero-fee model cater directly to traders, builders, and institutional flows.
• Community & Governance: Decentralized and transparent, with robust validator involvement from reputable firms and high network uptime—a testament to strong technical stewardship.
• Developer Momentum: Numerous DeFi apps, cross-chain integrations, and active governance proposals highlight an expanding and innovative community.

Volume, Liquidity & Market Positioning

• 24h Trading Volume: ~94M USD—a level confirming both liquidity depth and consistent market interest. This ensures efficient price discovery and low slippage, key for sophisticated traders and institutions alike.
• Dominance: While not the largest Layer-1 by cap, INJ’s niche focus, prime CEX listings, and expanding DeFi/NFT ecosystem deepen its profile among the top innovative blockchains.

Near-Term Catalysts

• Protocol Upgrades: The upcoming Injective Summit (June 26, 2025), further IA and stablecoin integrations, and scaling initiatives are likely to act as price catalysts.
• Institutional Adoption: Continuing inflows from large validators and cross-sector partnerships—especially in web3 finance infrastructure.
• Regulation: Progressive stances in PH and across Asia, as well as growing legal clarity for institutional asset managers, further derisk the investment context for INJ.

Investment Strategies

Short-Term (weeks to months)

• Opportunity: Strategic entries toward the $11.30–$12.00 support zone appear well-positioned, particularly ahead of high-profile events (Summit, protocol upgrades).
• Advantage: Post-correction, short-term reversal potential is significant, especially if resistance is reclaimed near $14–$15.

Medium-Term (several quarters)

• Play: With key ecosystem expansions and corporate partnerships, incremental adoption could amplify price momentum toward the $18–$22 range.
• Driving Factors: Launch of new DeFi primitives, volume spikes, and validator growth should progressively unlock higher valuation bands.

Long-Term (1–5 years)

• Conviction: A capped supply (max 100M INJ), proven operational resilience (billions of txs, 99.9% uptime), and exposure to the intersection of AI and DeFi define a strong case for multi-year appreciation.
• Structural Edge: Institutional and developer network effects place Injective favorably for compounding growth throughout the next crypto cycle.

Injective Price Forecast

Is Now the Right Time to Consider Injective?

Key Strengths at a Glance

• Robust institutional validation, now counting Google Cloud and Deutsche Telekom among core validators
• Scarce tokenomics (97.7M/100M circulating) and high operational reliability with 2B+ transactions
• Strong community and fast-growing DeFi/AI ecosystem embracing emerging market trends
• High on-chain and exchange liquidity, ensuring entry and exit flexibility for active managers

Forward-Looking Perspective

In light of improving macroeconomic tailwinds, Injective’s distinctive positioning at the crossroads of DeFi, Layer-1 scalability, and AI-driven innovation upholds its relevance as an increasingly attractive blockchain asset. Supported by a series of institutional integrations, progressive technical upgrades, and accelerating adoption, the fundamentals of Injective now justify renewed interest from both retail and professional investors.

Injective remains a highly dynamic cryptocurrency, offering standout potential for capital appreciation, provided risks are managed with discipline. Its recent price reset could be the springboard for a new growth phase—especially as the protocol delivers on its upcoming roadmap and capitalizes on the evolving DeFi landscape. For those seeking exposure to a future-ready, institutionally endorsed, and technologically advanced Layer-1, Injective could well mark the start of a new upward cycle in digital asset investing.

How to buy Injective?

It’s simple and secure to buy Injective (INJ) online through a regulated platform — even if you’re just getting started. You generally have two main options: spot purchase (where you actually own INJ tokens, stored in a crypto wallet), and crypto CFD trading (where you speculate on prices via derivatives, but don’t own the coin itself). The right method depends on your investment approach and risk appetite. For a detailed comparison of trusted platforms and their features for PH residents, see the comparison table further down this page.

Spot Purchase

When you buy Injective “on the spot,” you become the real owner of INJ tokens, which are then held in your digital wallet — either on the platform or moved to an external wallet for extra security. On most major platforms, you can buy INJ directly in Philippine pesos (PHP), and typical fees are a fixed commission, around 0.1%–0.3% per transaction (or a flat fee, depending on the platform and payment method).

Important Example

Example: Suppose the current price is $12.90 (around PHP 750) per INJ. For a PHP 58,000 investment (approx. $1,000), after a PHP 300 fee (about $5), you would receive about 77 INJ coins.
If INJ’s price increases 10%, your portfolio would now be worth about PHP 63,800 — a gross gain of PHP 5,800 (approx. $100), or +10% on your initial investment.

Trading via CFD

Trading Crypto CFDs on Injective means speculating on the INJ price without actually owning the tokens; your trade is a contract with the platform, and you gain (or lose) based on price differences. Fees for CFD trading typically include the spread (difference between buy/sell prices) and an overnight financing fee if you keep your position open longer than a day. CFDs let you use leverage, boosting your exposure — and potential gains or losses.

Important Example

Example: You invest PHP 58,000 (about $1,000) with a 5x leverage, getting market exposure worth PHP 290,000 (about $5,000).
If INJ rises by 8%, your position gains 8% × 5 = 40%. Your gain is PHP 23,200 (about $400) — not accounting for additional fees and possible losses if the market moves against you.

Final Advice

Before investing, always compare platform fees, security standards, and conditions — as they can significantly impact your results. The best method depends on your goals, appetite for risk, and prior experience with crypto. Take your time to check the platform comparison table below for PH-specific options that fit your strategy.

Our 7 tips for buying Injective

The latest news about Injective

Injective’s 24H price rose over 6%, signaling renewed positive sentiment despite annual volatility. In the past week, INJ’s market price demonstrated a marked recovery, climbing over 6% in 24 hours and reversing part of its earlier losses. This uptick is supported by sustained trading volumes (~$94M USD daily) and a neutral technical landscape (14-day RSI at 47.9), suggesting that INJ is regaining market traction amid overall DeFi sector volatility. For the Philippines, growing local awareness of such price momentum may fuel interest among retail and professional traders, especially given INJ’s availability on widely-used platforms such as Binance (which remains operational in the PH market), allowing for direct market entry.

Injective welcomed BitGo as a new institutional validator in June 2025, enhancing network credibility and security. The addition of BitGo—one of the world’s most trusted institutional-grade crypto custodians—as a validator on the Injective blockchain (announced this month) significantly boosts the protocol’s operational legitimacy. This is particularly relevant for institutional investors and regulated exchanges operating in the Philippines, where counterparty risk and compliance standards are scrutinized post-2024 crypto licensing reforms. BitGo’s integration is expected to create new confidence among Philippine-based investment advisors, family offices, and fintech startups evaluating DeFi infrastructure partners.

Injective’s innovative iAgent SDK is driving AI-DeFi integration, attracting developer interest in Southeast Asia. Recent advances around the iAgent SDK—a development toolkit enabling AI-driven DeFi applications—position Injective as a Layer-1 with unique value for builders across Asia-Pacific. Regional developer conferences, hackathons, and online communities in PH have highlighted this SDK as a promising route for startups to integrate machine learning and decentralized finance rails. The SDK lowers technical hurdles and aligns with the Filipino tech sector’s focus on fintech and digital innovation, further supported by the country’s young, mobile-first developer base.

Interoperability between Injective and Cosmos continues to widen cross-chain opportunities for PH-based users and projects. Injective’s close technical integration with the Cosmos ecosystem, reinforced by its zero-fee structure for certain transactions, is increasing its attractiveness among Filipino DeFi enthusiasts and cross-chain asset managers. This interoperability supports local innovation, as builders in the Philippines can seamlessly deploy DeFi markets or derivatives both within Injective and across the broader Cosmos network, expanding their target user base without hefty transaction costs.

Upcoming Injective Summit 2025 catalyzes global and regional interest, with special focus on DeFi and AI infrastructures. The anticipated Injective Summit on June 26, 2025, is already drawing attention from Asian institutional players, including those based in the Philippines, especially as the agenda will be addressing DeFi, AI, and stablecoin infrastructure. Historically, such events have coincided with heightened trading activity and speculative inflows from Southeast Asia, and this edition is expected to foster new partnerships and drive awareness of INJ’s ecosystem within the local Web3, fintech, and venture capital communities.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.